• LAST PRICE
    0.3207
  • TODAY'S CHANGE (%)
    Trending Down-0.0120 (-3.6069%)
  • Bid / Lots
    0.3258/ 2
  • Ask / Lots
    0.3482/ 13
  • Open / Previous Close
    0.3327 / 0.3327
  • Day Range
    Low 0.3207
    High 0.3531
  • 52 Week Range
    Low 0.2600
    High 5.4700
  • Volume
    47,592
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.3327
TimeVolumeGLMD
09:50 ET19000.3327
10:03 ET84330.3327
10:46 ET1000.3327
11:06 ET2400.3328
11:36 ET20000.3405
11:45 ET2000.34001
11:47 ET4700.34
02:04 ET6800.353
02:06 ET18000.344051
02:11 ET38220.3327
02:24 ET4000.3349
02:26 ET1000.3348
02:29 ET79000.3299
02:45 ET26000.3347
02:54 ET25640.325001
03:09 ET50000.3274
03:34 ET20000.3208
03:43 ET54000.3207
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGLMD
Galmed Pharmaceuticals Ltd
2.1M
-0.1x
---
United StatesSCNI
Scinai Immunotherapeutics Ltd
2.0M
0.0x
---
United StatesSLRX
Salarius Pharmaceuticals Inc
2.0M
-1.3x
---
United StatesPXMD
PaxMedica Inc
2.0M
0.0x
---
United StatesPBLA
Panbela Therapeutics Inc
2.0M
0.0x
---
United StatesCWBR
CohBar Inc
2.3M
-0.2x
---
As of 2024-06-17

Company Information

Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).

Contact Information

Headquarters
16 Tiomkin StreetTEL AVIV-YAFO, Israel 6578317
Phone
---
Fax
---

Executives

President, Chief Executive Officer, Director
Allen Baharaff
Chief Financial Officer
Doron Cohen
Chief Operating Officer, Data Protection Officer
Guy Nehemya
Chief Accounting Officer
Yohai Stenzler
Chief Scientific Officer
Liat Hayardeny

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.1M
Revenue (TTM)
$0.00
Shares Outstanding
6.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.71
EPS
$-2.83
Book Value
$2.75
P/E Ratio
-0.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.